[THE INVESTOR] On Oct. 18, InBody (041830) increased 4.07% to 37,100 won (US$32.85). It had declined 2.02% through the past month. Standard deviation, the volatility index for stock price, was 2% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of InBody was around the average of that of its peer group, but the investment return for one month was at an absolutely low level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.0%. In spite of stock price decline, the return-on-risk remained around the average of its peer group. However, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 0.0, and thus it is hard to say that the industrial comparison performance was positive.

Yesterday, institutions and foreigners bought 887 shares and 17,833 shares. As a shareholding sum by investor group for the past four weeks, foreigners have bought 191,713 shares with a maintenance of shareholding. However, during the same period, institutions have sold 19,412 shares with a selling trend and individuals have sold 172,301 shares with a decreasing position.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.